UniProt ID | HBEGF_HUMAN | |
---|---|---|
UniProt AC | Q99075 | |
Protein Name | Proheparin-binding EGF-like growth factor | |
Gene Name | HBEGF | |
Organism | Homo sapiens (Human). | |
Sequence Length | 208 | |
Subcellular Localization |
Heparin-binding EGF-like growth factor: Secreted, extracellular space. Mature HB-EGF is released into the extracellular space and probably binds to a receptor. Proheparin-binding EGF-like growth factor: Cell membrane Single-pass type I membrane pro |
|
Protein Description | Growth factor that mediates its effects via EGFR, ERBB2 and ERBB4. Required for normal cardiac valve formation and normal heart function. Promotes smooth muscle cell proliferation. May be involved in macrophage-mediated cellular proliferation. It is mitogenic for fibroblasts, but not endothelial cells. It is able to bind EGF receptor/EGFR with higher affinity than EGF itself and is a far more potent mitogen for smooth muscle cells than EGF. Also acts as a diphtheria toxin receptor.. | |
Protein Sequence | MKLLPSVVLKLFLAAVLSALVTGESLERLRRGLAAGTSNPDPPTVSTDQLLPLGGGRDRKVRDLQEADLDLLRVTLSSKPQALATPNKEEHGKRKKKGKGLGKKRDPCLRKYKDFCIHGECKYVKELRAPSCICHPGYHGERCHGLSLPVENRLYTYDHTTILAVVAVVLSSVCLLVIVGLLMFRYHRRGGYDVENEEKVKLGMTNSH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MKLLPSVVLKLFL --CCCHHHHHHHHHH | 25.48 | 23909892 | |
37 | O-linked_Glycosylation | RRGLAAGTSNPDPPT HHHHHCCCCCCCCCC | 22.17 | 23234360 | |
37 | Phosphorylation | RRGLAAGTSNPDPPT HHHHHCCCCCCCCCC | 22.17 | 22468782 | |
38 | O-linked_Glycosylation | RGLAAGTSNPDPPTV HHHHCCCCCCCCCCC | 45.51 | 23234360 | |
38 | Phosphorylation | RGLAAGTSNPDPPTV HHHHCCCCCCCCCCC | 45.51 | 22468782 | |
44 | O-linked_Glycosylation | TSNPDPPTVSTDQLL CCCCCCCCCCHHHCE | 32.26 | 22171320 | |
44 | Phosphorylation | TSNPDPPTVSTDQLL CCCCCCCCCCHHHCE | 32.26 | - | |
46 | O-linked_Glycosylation | NPDPPTVSTDQLLPL CCCCCCCCHHHCEEC | 28.83 | OGP | |
47 | Phosphorylation | PDPPTVSTDQLLPLG CCCCCCCHHHCEECC | 24.35 | 22468782 | |
47 | O-linked_Glycosylation | PDPPTVSTDQLLPLG CCCCCCCHHHCEECC | 24.35 | 22171320 | |
75 | O-linked_Glycosylation | DLDLLRVTLSSKPQA CCHHHHHHCCCCCCC | 17.94 | UniProtKB CARBOHYD | |
75 | O-linked_Glycosylation | DLDLLRVTLSSKPQA CCHHHHHHCCCCCCC | 17.94 | 1556128 | |
77 | O-linked_Glycosylation | DLLRVTLSSKPQALA HHHHHHCCCCCCCCC | 27.27 | 55828397 | |
78 | O-linked_Glycosylation | LLRVTLSSKPQALAT HHHHHCCCCCCCCCC | 52.01 | 55828403 | |
85 | O-linked_Glycosylation | SKPQALATPNKEEHG CCCCCCCCCCHHHHC | 28.39 | 55828409 | |
85 | O-linked_Glycosylation | SKPQALATPNKEEHG CCCCCCCCCCHHHHC | 28.39 | 1556128 | |
95 | Acetylation | KEEHGKRKKKGKGLG HHHHCCCCCCCCCCC | 63.42 | 88663 | |
96 | Acetylation | EEHGKRKKKGKGLGK HHHCCCCCCCCCCCC | 71.44 | 70655 | |
97 | Acetylation | EHGKRKKKGKGLGKK HHCCCCCCCCCCCCC | 69.74 | 61159 | |
99 | Acetylation | GKRKKKGKGLGKKRD CCCCCCCCCCCCCCC | 60.90 | 70651 | |
103 | Acetylation | KKGKGLGKKRDPCLR CCCCCCCCCCCHHHH | 50.07 | 70643 | |
104 | Acetylation | KGKGLGKKRDPCLRK CCCCCCCCCCHHHHH | 61.30 | 70647 | |
199 | Ubiquitination | YDVENEEKVKLGMTN CCCCCHHHEECCCCC | 38.19 | 29901268 | |
207 | Phosphorylation | VKLGMTNSH------ EECCCCCCC------ | 22.77 | 16557002 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of HBEGF_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HBEGF_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ZBT16_HUMAN | ZBTB16 | physical | 14597771 | |
ZBT16_HUMAN | ZBTB16 | physical | 15219838 | |
EGFR_HUMAN | EGFR | physical | 12725245 | |
BAG1_HUMAN | BAG1 | physical | 11340068 | |
BCL6_HUMAN | BCL6 | physical | 19337254 | |
BCL6_HUMAN | BCL6 | physical | 17392284 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
O-linked Glycosylation | |
Reference | PubMed |
"Human urinary glycoproteomics; attachment site specific analysis ofN-and O-linked glycosylations by CID and ECD."; Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.; Mol. Cell. Proteomics 0:0-0(2011). Cited for: GLYCOSYLATION AT THR-44 AND THR-47, STRUCTURE OF CARBOHYDRATES, ANDMASS SPECTROMETRY. | |
"Structure of heparin-binding EGF-like growth factor. Multiple forms,primary structure, and glycosylation of the mature protein."; Higashiyama S., Lau K., Besner G.E., Abraham J.A., Klagsbrun M.; J. Biol. Chem. 267:6205-6212(1992). Cited for: PROTEIN SEQUENCE OF 63-141 AND 143-148, AND GLYCOSYLATION AT THR-75AND THR-85. |